Clinical Trials Directory

Trials / Completed

CompletedNCT04532411

COVID-19 Testing Sample Acquisition Throughput and Efficiency

Evaluation of SARS-CoV-2 Sample Acquisition Efficiency and PPE Usage With and Without the Hexapod Personal Protective Booth

Status
Completed
Phase
Study type
Observational
Enrollment
28,948 (actual)
Sponsor
Massachusetts General Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

This QI project seeks to evaluate the relative test sample acquisition throughput, personal protective equipment utilization, and relative operational costs of provider-administered COVID-19 (SARS-CoV-2) nasal samples with and with the use of HEPA-filtered, positive pressure isolation booths.

Detailed description

Beginning in March 2020, the MGH began outpatient testing for COVID-19 (SARS-CoV-2) utilizing a provider-administered nasal swab samples. This was administered with infection control protocols utilizing full PPE protection for health providers who would don and doff gowns and gloves with each sample acquisition. With an aim to decrease PPE usage and increase efficiency, personal protective booths with HEPA-filtered air called "Hexapods" were employed, after infection control approval, within the MGH system beginning on April 16, 2020. Ambulatory Care Management at MGH systematically monitors testing completed and PPE usage on a weekly basis. Managers in charge of personnel changes shared necessary team structures and median salaries for different personnel involved with sample acquisition. MGH Materials management were able to report on costs related to consumable supplies used during testing. In this investigation, this routinely collected data and averaged timed sample collection observations were used to compare before and after the Hexapod utilization.

Conditions

Interventions

TypeNameDescription
OTHERPersonal Protective Testing BoothHealth personnel who utilize the Hexapod will remain in the booth and utilize durable gloves attached to ports through a plexiglass wall in order to administer a nasal swab for SARS-CoV-2 (COVID-19) testing. Patient escorts and housekeeping/sanitation staff perform additional tasks outside of the booth such as escorting the patient to the correct testing bay and dropping off testing vials and printed information, collect samples and deposit in the appropriate location after testing is complete, and sanitizing the patient bay before a subsequent patient is tested there.

Timeline

Start date
2020-03-01
Primary completion
2020-09-30
Completion
2020-09-30
First posted
2020-08-31
Last updated
2023-10-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04532411. Inclusion in this directory is not an endorsement.